Table 1.
Clinical characteristics of the study population.
| Variables | no. (%) |
|---|---|
| Sex | |
| Male | 34 (68) |
| Female | 16 (32) |
| Type of comorbidity | |
| Diabetes mellitus | 11 (22) |
| Asthma/ Chronic lung disease | 8 (16) |
| Hypertension | 22 (44) |
| Dyslipidemia/ Obesity | 26 (52) |
| Cancer | 2 (1) |
| Immunosuppression | 2 (1) |
| Number of comorbidities | |
| One | 17 (34) |
| Two or more | 21 (42) |
| None | 12 (24) |
| On mechanical ventilation | 50 (100) |
| Acute renal failure | 15 (30) |
| Acute Physiology And Chronic Health Evaluation II | |
| <10 | 9 (18) |
| 10–15 | 17 (34) |
| >15 | 24 (48) |
| Antiviral or anti-inflammatory treatment | |
| Remdesivir | 11 (22) |
| Corticosteroids | 50 (100) |
| Tocilizumab | 19 (38) |
| Adrenalin | 24 (48) |